Skip to main content
. 2017 Dec 14;10(2):304–314. doi: 10.1080/19420862.2017.1409320

Figure 1.

Figure 1.

FMAT binding of BBB targeting hIgG1TM to brain capillary endothelial cells. FMAT binding assay to confirm the binding of BBB targeting hIgGs identified from epitope competition bEND.3 phage selections. FMAT assay binding curves of BBB hIgG1, BBB (○) and eight BBB targeting hIgGs, BBBt0626 (•), BBBt0632 (▾), BBBt0726 (▴), BBBt0654 (♦), BBBt0717 (◊), BBBt0727 (x), BBBt0732 (+), BBBt0754 (□) and isotype control hIgG1 (▪). (A) BBB targeting hIgGs binding to mouse brain endothelial (bEND.3) cells (B) BBB targeting hIgGs binding to Rat Brain Capillary Endothelial Cells and (C) BBB targeting hIgGs binding to human D3 Brain Capillary Endothelial Cells.